Genomic Stocks Continue Slide | GenomeWeb

Genomics stocks continue to lead the biotech sectors on a downward slide Wednesday morning.

Celera Genomics dropped another 4.7 percent by mid-day after shedding 7 percent Tuesday.Incyte Genomics slipped another 4 percent following a 4.2 percent decline the day before. And the market chipped an additional 5.4 percent of Affymetrix stock following a previous day decline of 5.1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: a global genetic interaction map for Saccharomyces cerevisiae, and progress made in genomics, precision medicine, and therapeutics.

The price of plane tickets can affect how scientists in different countries choose to collaborate with each other, NPR reports.

The Annals of Improbable Research has awarded the 2016 Ig Nobel Prizes.

Scientific American alleges that the FDA has been "arm-twisting journalists into relinquishing their reportorial independence."